English
Regional settings| Spread | 0.60 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ CHF 5,000.00 Short position overnight fee ~ CHF 4,000.00 | -0.014982% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ CHF 5,000.00 Short position overnight fee ~ CHF 4,000.00 | -0.00724% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | CHF | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Switzerland | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 70.1 |
| Open | 69.65 |
| 1-Year Change | -9.72% |
| Day's Range | 69.65 - 70.45 |
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
BRIEF: For the fiscal year ended 31 December 2021, Galenica AG revenues increased 10% to SF3.83B. Net income applicable to common stockholders decreased 3% to SF167.7M. Revenues reflect Products & Care segment increase of 14% to SF1.83B, Logistics & IT segment increase of 7% to SF2B, Other countries segment increase of 13% to SF30.6M. Net income was offset by Personnel costs increase of 17% to SF518.9M (expense).
